Regenics vs Sprout Health: Compounded GLP-1, price and speed
Choosing between Regenics vs Sprout Health comes down to whether you prioritize lower promotional pricing and a secondary peptide option or faster approval and clear outcome framing. Early verdict: Regenics is the lower-cost promotional entry with a Sermorelin add-on and nurse-practitioner-led care; Sprout Health is for faster, low-friction starts and explicit outcome claims.
Explore Regenics pricing and options
How Regenics and Sprout Health differ at a glance
Both providers deliver telehealth GLP-1 care with compounded medications and require a licensed clinician to determine medical appropriateness, and both note that compounded medications are not FDA-approved finished products. The most distinctive supported differences are: promotional first-month pricing and renewal rates, clinician staffing and add-on therapies, approval speed and onboarding friction, outcome framing, and ongoing cost after introductory pricing.
1. Promotional pricing and renewal profiles
Regenics markets compounded semaglutide at $139 for the first month and tirzepatide at $189 for the first month, with stated renewals at $199 and $279 respectively. Promotional pricing applies to the first month only. Sprout Health offers $50 off the first month, bringing the initial cost to $199, with an ongoing rate of $249/month after the discounted first month. Compare the first-month entry and the higher post-discount ongoing cost when planning a multi-month program.
See Regenics first-month details
2. Clinician model and available add-ons
Regenics is described as nurse-practitioner-led GLP-1 care and explicitly offers a Sermorelin peptide therapy add-on (15mg injectable priced at $399 in the source). The provider states that licensed nurse practitioners review intake before prescribing and that the pharmacy network is LegitScript certified. Sprout Health is presented as a licensed telehealth GLP-1 platform with rapid clinician review for prescriptions but the source does not list Sermorelin or a secondary peptide line.
3. Approval speed and onboarding friction
Sprout Health emphasizes a lightning-quick approval process and positions itself for patients who want a fast, low-friction entry to GLP-1 therapy. Regenics does not make the same speed claim; its materials emphasize clinician review by nurse practitioners and pharmacy certification. If onboarding speed is a priority, Sprout Health is presented as the faster option in the source.
4. Outcome messaging and expectations
Sprout Health frames outcomes as 10–26% body weight loss over 12 months, based on GLP-1 clinical outcome literature, while noting individual results vary and offering no formal outcome guarantee. Regenics does not provide an outcome percentage in the supplied material; its messaging centers on access to compounded semaglutide and tirzepatide and the availability of Sermorelin.
| Criteria | Regenics | Sprout Health |
|---|---|---|
| First-month price | Semaglutide $139, tirzepatide $189 (first month) | $50 off first month to $199 |
| Ongoing price | Semaglutide renews $199/mo, tirzepatide $279/mo | $249/month ongoing |
| Clinician model | Licensed nurse practitioners review intake | Licensed telehealth clinicians with fast review |
| Add-on therapies | Sermorelin peptide offered | No secondary peptide listed |
| Approval speed | No lightning-quick claim; clinician review emphasized | Lightning-quick approval process claimed |
| Outcome framing | No explicit percent outcome cited in source | 10–26% body weight loss over 12 months framed |
| Regulatory note | Compounded meds not FDA-approved finished products | Compounded meds note; branded vs compounded distinction mentioned |
5. Shipping, certification, and payment
Regenics states free shipping with medication compounded in the USA and notes FSA/HSA eligibility and a LegitScript certified pharmacy network. Sprout Health is presented as fully online with home delivery following approval and operates on a direct-pay model; the source notes it does not bill insurance and that the $50 first-month discount applies to new patients.
Check Sprout Health offer and approval timeline
Weighing costs, speed, and program features
Direct comparison: Regenics offers lower promotional starting prices and a nurse-practitioner-led approach with a Sermorelin add-on and free shipping from U.S. compounding pharmacies, while Sprout Health sells a faster onboarding process with explicit outcome framing and a $50 first-month discount that increases to $249/month ongoing. Both require clinician determination of medical appropriateness and both disclose that compounded medications are not FDA-approved finished products.
Start with Regenics pricing and care model
Conclusion and who each is best for
Regenics vs Sprout Health boils down to tradeoffs between initial cost, ongoing cost, onboarding speed, and available add-ons. Choose Regenics if you want the lowest promotional first-month price, nurse-practitioner oversight, a Sermorelin peptide option, and free shipping from U.S. compounding pharmacies. Choose Sprout Health if you prioritize lightning-quick approval, a clear 10–26% outcome framing over 12 months, and a streamlined, fast-entry telehealth process.
Final note: Both providers emphasize clinician review and that compounded medications are not FDA-approved finished products; any treatment is available only when a licensed clinician determines it is medically appropriate.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →